Notice: This company has been marked as potentially delisted and may not be actively trading. Taro Pharmaceutical Industries (TARO) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Meet Man, started business with only Rs 2000 in one room with 2 employees, son of pharma distributor, now owner of Rs…November 12, 2024 | msn.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!November 10, 2024 | globenewswire.comMedicus Pharma readies for IPO as it targets $20B industryNovember 8, 2024 | bizjournals.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!November 4, 2024 | globenewswire.comResearchers develop more selective proteasome inhibitors for use in the pharmaceutical industryOctober 30, 2024 | msn.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 29, 2024 | globenewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 23, 2024 | globenewswire.comItaly’s Digital Tax Gambit—Will US Trade Retaliation Follow?October 11, 2024 | forbes.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 11, 2024 | globenewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!October 6, 2024 | globenewswire.comIran-Israel conflict: These listed companies on D-Street may feel jittery; here's whyOctober 5, 2024 | msn.comMiddle East Crisis: What It Means For India's 14 Listed Companies & 4 IT Majors Linked To IsraelOctober 4, 2024 | msn.comMiddle East crisis: Indian companies linked to Israel you should know aboutOctober 3, 2024 | msn.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 30, 2024 | globenewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 24, 2024 | globenewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 23, 2024 | prnewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 18, 2024 | globenewswire.comKairos Pharma Closing of $6.2 Million Initial Public OfferingSeptember 18, 2024 | tmcnet.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 15, 2024 | prnewswire.comTARO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Taro Pharmaceutical Industries Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!September 12, 2024 | globenewswire.comAdemi LLP announces the filing of Class Action Lawsuit against Taro Pharmaceutical Industries Ltd. and other DefendantsSeptember 10, 2024 | prnewswire.comBrandes Investment Partners Amplifies Stake in CAE Inc, Highlighting Strategic Portfolio ...August 19, 2024 | finance.yahoo.comSun Pharma Q1 net profit jumps 40.2 pc to Rs 2,835.62 crAugust 2, 2024 | msn.comSun Pharma Q1 Results: Net profit at 40.2% year-on-yearAugust 2, 2024 | msn.comSun Pharma Q1 Results: Net profit jumps 40% to ₹2,836 crore, revenue up 6% YoYAugust 2, 2024 | msn.comPharma aims to deliver personalized cancer therapies more quicklyJuly 24, 2024 | yahoo.comFocus: Pharma aims to deliver personalized cancer therapies more quicklyJuly 24, 2024 | reuters.comSun Pharma Completes Taro MergerJune 24, 2024 | prnewswire.comTaro Pharmaceutical Industries (NYSE:TARO) Coverage Initiated at StockNews.comStockNews.com began coverage on Taro Pharmaceutical Industries in a research report on Saturday. They set a "strong-buy" rating on the stock.June 22, 2024 | marketbeat.comTaro Pharmaceutical Industries (NYSE:TARO) Sees Unusually-High Trading VolumeTaro Pharmaceutical Industries (NYSE:TARO) Sees Unusually-High Trading VolumeJune 20, 2024 | marketbeat.comTaro Pharmaceutical Industries (NYSE:TARO) Now Covered by StockNews.comStockNews.com began coverage on shares of Taro Pharmaceutical Industries in a report on Wednesday. They issued a "strong-buy" rating on the stock.May 29, 2024 | marketbeat.comSun Pharma eyes expansion of speciality bizMay 24, 2024 | msn.comTaro Shareholders Approve Merger with Sun PharmaMay 23, 2024 | prnewswire.comSun Pharma Q4 Results: Profit rises by 33.8% to Rs 2654.58 crore, dividend of Rs 5 announcedMay 22, 2024 | msn.comTaro: Fiscal Q4 Earnings SnapshotMay 20, 2024 | washingtonpost.comTaro Provides Results for Year Ended March 31, 2024May 20, 2024 | businesswire.comShareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun Pharmaceutical Industries Limited.May 20, 2024 | prnewswire.comTaro Pharmaceutical Industries is about to announce its earnings — here's what Wall Street expectsMay 19, 2024 | markets.businessinsider.comTaro to Release Full Year Results on May 20, 2024May 15, 2024 | businesswire.comTaro Pharma Shareholders Get Advise To Vote To Support Merger With Sun PharmaMay 8, 2024 | markets.businessinsider.comLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma MergerMay 8, 2024 | finance.yahoo.comLeading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma MergerMay 8, 2024 | businesswire.com3 A-Rated Pharma Stocks to Buy for Long-Term GrowthMay 2, 2024 | stocknews.comThe Canadian Association of Optometrists Releases a New "GetEyeWise" Digital Campaign to Bring Awareness About Eye Health and Vision CareMay 1, 2024 | financialpost.comTaro Pharmaceutical Board Relies on Flawed Analysis to Shortchange Minority ShareholdersApril 23, 2024 | finance.yahoo.comMiddle East crisis escalation may hurt pharma exportsApril 18, 2024 | msn.comTaro Pharmaceutical Industries Ltd TALApril 17, 2024 | morningstar.comJNJ Earnings Forecast - Is Pharmaceutical Industry Set for Shake-up?April 15, 2024 | stocknews.comTaro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.April 15, 2024 | businesswire.comTaro Pharmaceutical Industries Ltd. (NYSE:TARO) Short Interest UpdateTaro Pharmaceutical Industries Ltd. (NYSE:TARO - Get Free Report) was the target of a significant drop in short interest in March. As of March 31st, there was short interest totalling 39,800 shares, a drop of 32.0% from the March 15th total of 58,500 shares. Approximately 0.5% of the company's stock are sold short. Based on an average trading volume of 51,900 shares, the days-to-cover ratio is currently 0.8 days.April 12, 2024 | marketbeat.com Get Taro Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TARO and its competitors with MarketBeat's FREE daily newsletter. Email Address TARO Media Mentions By Week TARO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TARO News Sentiment▼-1.320.78▲Average Medical News Sentiment TARO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TARO Articles This Week▼01▲TARO Articles Average Week Get Taro Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TARO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BBIO News Today LEGN News Today ELAN News Today IONS News Today CYTK News Today CORT News Today NUVL News Today GRFS News Today TLX News Today ALKS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TARO) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Taro Pharmaceutical Industries Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Taro Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
